125 related articles for article (PubMed ID: 25985177)
1. Transcriptomics: the key to biomarker discovery during tuberculosis?
van Rensburg IC; Loxton AG
Biomark Med; 2015; 9(5):483-95. PubMed ID: 25985177
[TBL] [Abstract][Full Text] [Related]
2. Enabling biomarkers for tuberculosis control.
Maertzdorf J; Weiner J; Kaufmann SH
Int J Tuberc Lung Dis; 2012 Sep; 16(9):1140-8. PubMed ID: 22871324
[TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
4. The quest for biomarkers in tuberculosis.
Parida SK; Kaufmann SH
Drug Discov Today; 2010 Feb; 15(3-4):148-57. PubMed ID: 19854295
[TBL] [Abstract][Full Text] [Related]
5. Novel strategies to identify biomarkers in tuberculosis.
Jacobsen M; Mattow J; Repsilber D; Kaufmann SH
Biol Chem; 2008 May; 389(5):487-95. PubMed ID: 18953715
[TBL] [Abstract][Full Text] [Related]
6. Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy.
Bloom CI; Graham CM; Berry MP; Wilkinson KA; Oni T; Rozakeas F; Xu Z; Rossello-Urgell J; Chaussabel D; Banchereau J; Pascual V; Lipman M; Wilkinson RJ; O'Garra A
PLoS One; 2012; 7(10):e46191. PubMed ID: 23056259
[TBL] [Abstract][Full Text] [Related]
7. Host Transcriptomics as a Tool to Identify Diagnostic and Mechanistic Immune Signatures of Tuberculosis.
Burel JG; Babor M; Pomaznoy M; Lindestam Arlehamn CS; Khan N; Sette A; Peters B
Front Immunol; 2019; 10():221. PubMed ID: 30837989
[TBL] [Abstract][Full Text] [Related]
8. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers of treatment response in clinical trials of novel antituberculosis agents.
Perrin FM; Lipman MC; McHugh TD; Gillespie SH
Lancet Infect Dis; 2007 Jul; 7(7):481-90. PubMed ID: 17524807
[TBL] [Abstract][Full Text] [Related]
10. A novel blood test for tuberculosis prevention and treatment.
Penn-Nicholson A; Scriba TJ; Hatherill M; White RG; Sumner T
S Afr Med J; 2016 Dec; 107(1):4-5. PubMed ID: 28112082
[No Abstract] [Full Text] [Related]
11. Tuberculosis.
Frieden TR; Sterling TR; Munsiff SS; Watt CJ; Dye C
Lancet; 2003 Sep; 362(9387):887-99. PubMed ID: 13678977
[TBL] [Abstract][Full Text] [Related]
12. Tuberculosis biomarkers discovery: developments, needs, and challenges.
Wallis RS; Kim P; Cole S; Hanna D; Andrade BB; Maeurer M; Schito M; Zumla A
Lancet Infect Dis; 2013 Apr; 13(4):362-72. PubMed ID: 23531389
[TBL] [Abstract][Full Text] [Related]
13. Overcoming the global crisis: "yes, we can", but also for TB ... ?
Ottenhoff TH
Eur J Immunol; 2009 Aug; 39(8):2014-20. PubMed ID: 19672895
[TBL] [Abstract][Full Text] [Related]
14. Global drug-resistance patterns and the management of latent tuberculosis infection in immigrants to the United States.
Khan K; Muennig P; Behta M; Zivin JG
N Engl J Med; 2002 Dec; 347(23):1850-9. PubMed ID: 12466510
[TBL] [Abstract][Full Text] [Related]
15. Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities.
McNerney R; Maeurer M; Abubakar I; Marais B; McHugh TD; Ford N; Weyer K; Lawn S; Grobusch MP; Memish Z; Squire SB; Pantaleo G; Chakaya J; Casenghi M; Migliori GB; Mwaba P; Zijenah L; Hoelscher M; Cox H; Swaminathan S; Kim PS; Schito M; Harari A; Bates M; Schwank S; O'Grady J; Pletschette M; Ditui L; Atun R; Zumla A
J Infect Dis; 2012 May; 205 Suppl 2():S147-58. PubMed ID: 22496353
[TBL] [Abstract][Full Text] [Related]
16. Achieving STOP TB Partnership goals: perspectives on development of new diagnostics, drugs and vaccines for tuberculosis.
Mwaba P; McNerney R; Grobusch MP; O'Grady J; Bates M; Kapata N; Maeurer M; Zumla A
Trop Med Int Health; 2011 Jul; 16(7):819-27. PubMed ID: 21489070
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers for TB treatment response: challenges and future strategies.
Walzl G; Ronacher K; Djoba Siawaya JF; Dockrell HM
J Infect; 2008 Aug; 57(2):103-9. PubMed ID: 18649943
[TBL] [Abstract][Full Text] [Related]
18. CDC/NIH Workshop. Tuberculosis biomarker and surrogate endpoint research roadmap.
Nahid P; Saukkonen J; Mac Kenzie WR; Johnson JL; Phillips PP; Andersen J; Bliven-Sizemore E; Belisle JT; Boom WH; Luetkemeyer A; Campbell TB; Eisenach KD; Hafner R; Lennox JL; Makhene M; Swindells S; Villarino ME; Weiner M; Benson C; Burman W; ;
Am J Respir Crit Care Med; 2011 Oct; 184(8):972-9. PubMed ID: 21737585
[TBL] [Abstract][Full Text] [Related]
19. Systems biology of tuberculosis.
Chandra N; Kumar D; Rao K
Tuberculosis (Edinb); 2011 Sep; 91(5):487-96. PubMed ID: 21459043
[TBL] [Abstract][Full Text] [Related]
20. [Tuberculosis].
Günther G; Heyckendorf J; Herzmann C; Lange C
Dtsch Med Wochenschr; 2012 May; 137(18):947-58; quiz 959-62. PubMed ID: 22538419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
